Overview For the treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida and Histophilus somni in beef and nonlactating dairy cattle.

  • For the control of respiratory disease in beef and nonlactating dairy cattle at high risk of developing BRD associated with Mannheimia haemolytica, Pasteurella multocida and Histophilus somni
  • Contains 180 mg tildipirosin, a semi-synthetic macrolide antibiotic
  • Ready-to-use solution
  • Subcutaneous injection